The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

Addyi, the first FDA-approved medication for low libido in women under 65, offers a new treatment option. Learn about its ...

Addyi (flibanserin) was cleared a decade ago to treat low sex drive in women before menopause. A new FDA action allows ...

In the last year or so, health influencers — and a lot of women on social media — have talked up testosterone therapy as a ...

The US Food and Drug Administration (FDA) has approved the medication Addyi (flibanserin) as a “female Viagra” for use to treat low sex drive in women after menopause under the age of 65.Addyi, a pill ...

While the expanded approval fulfills an unmet meet in postmenopausal women, its benefits are marginal in that population.